Cargando…
Development and Characterization of a Camelid Single Domain Antibody–Urease Conjugate That Targets Vascular Endothelial Growth Factor Receptor 2
Angiogenesis is the process of new blood vessel formation and is essential for a tumor to grow beyond a certain size. Tumors secrete the pro-angiogenic factor vascular endothelial growth factor, which acts upon local endothelial cells by binding to vascular endothelial growth factor receptors (VEGFR...
Autores principales: | Tian, Baomin, Wong, Wah Yau, Uger, Marni D., Wisniewski, Pawel, Chao, Heman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566995/ https://www.ncbi.nlm.nih.gov/pubmed/28871252 http://dx.doi.org/10.3389/fimmu.2017.00956 |
Ejemplares similares
-
Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
por: Arbabi-Ghahroudi, Mehdi
Publicado: (2017) -
Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview
por: Goldman, Ellen R., et al.
Publicado: (2017) -
Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases
por: Fernandes, Carla F. C., et al.
Publicado: (2017) -
Properties, production, and applications of camelid single-domain antibody fragments
por: Harmsen, M. M., et al.
Publicado: (2007) -
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments †
por: Arbabi-Ghahroudi, Mehdi
Publicado: (2022)